Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 25 February 2026
Nerandomilast for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis ID6446Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC